39th Interscience Conference on Antimicrobial Agents and Chemotherapy of the American Society for Microbiology
L E Lawrence1, M J Pucci, M Frosco
1Bristol-Myers Squibb, 5 Research Parkway, Wallingford, CT 06492, USA.
Abstract:
The 39th ASM ICAAC Meeting, attended by over 16,000 delegates, highlighted numerous late-stage development antibacterials. The presentation of over 600 reports (posters, symposia and oral presentations) regarding resistance emergence underscores the evolving landscape of antibiotic susceptibility worldwide. Although bacterial genomic efforts are slowly expanding the potential sources of novel targets, the established antibacterial classes, including quinolones, beta-lactams, protein synthesis inhibitors and carbapenems, were most prevalent among the presentations. Quinolones dominated this conference, with many presentations of moxifloxacin (> 72 presentations), gatifloxacin (> 66 presentations) and gemifloxacin (> 59 presentations). The new class of antibacterials, the oxazolidinones, represented by Linezolid, was also highlighted.
Insights
The 39th ASM ICAAC Meeting showcased late-stage antibacterials, with quinolones like moxifloxacin and gatifloxacin being most prominent. Resistance emergence remains a key concern, driving research into novel antibiotic development.
Area of Science:
- Microbiology
- Infectious Diseases
- Pharmacology
Background:
- The 39th ASM ICAAC Meeting convened over 16,000 delegates to discuss advancements in antibacterial research.
- Over 600 reports addressed the critical issue of antibiotic resistance emergence and its global impact on susceptibility patterns.
Purpose of the Study:
- To summarize the key antibacterial agents and research trends presented at the 39th ASM ICAAC Meeting.
- To highlight the prevalence of established antibacterial classes and emerging resistance concerns.
Main Methods:
- Analysis of presentations (posters, symposia, oral) from the 39th ASM ICAAC Meeting.
- Categorization of presented antibacterials by class and specific agents.
- Identification of research focus areas, particularly resistance emergence.
Main Results:
- Established antibacterial classes, including quinolones, beta-lactams, protein synthesis inhibitors, and carbapenems, were most frequently presented.
- Quinolones, specifically moxifloxacin, gatifloxacin, and gemifloxacin, dominated the conference presentations.
- The oxazolidinone class, represented by Linezolid, was also a notable focus.
Conclusions:
- The conference underscored the ongoing challenge of antibiotic resistance and the need for continued development of effective treatments.
- Established antibacterial classes remain central to research efforts, with quinolones showing significant attention.
- Novel antibiotic classes like oxazolidinones represent a promising avenue for addressing resistant bacterial infections.
More Related Videos
12:03Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method
Published on: April 18, 2019
09:59Application of the Intelligent High-Throughput Antimicrobial Sensitivity Testing/Phage Screening System and Lar Index of Antimicrobial Resistance
Published on: July 21, 2023
Related Concept Videos
Antibiotic Selection
Microorganisms in Medicine and Therapeutics
Antimicrobial Effectiveness
iChip
Automated Microbial Diagnostics
Clinical Significance of Antibiotic Resistance
